Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.26/33143 |
Resumo: | Introduction. Adherence in allergen immunotherapy is crucial for its efficacy. At least 3 years of treatment are recommended for achieving a long-term modifying effect. Objectives. To assess patient’s adherence and to identify determinant factors for allergen subcutaneous immunotherapy (SCIT) suspension in patients with respiratory allergy. Methods. Retrospective analysis of the medical record of patients submitted to SCIT between January 2013 and December 2016 in our Department. Results. 323 patients were included: 52% female; mean age 30 ± 13 years; average treatment time 19 ± 13 months. 52 patients (16%) stopped SCIT: 54% female; mean age 30 ± 9 years; average treatment time 12 ± 6 months; 67% dropped the treatment during the 1st year, 27% in the 2nd and 6% during the 3rd year of treatment. Adherence rate determined was 77%. The most frequent reasons for withdrawal were due to economic reasons (47.9%), followed by patients’ perception of no clinical improvement (23%) and change to sublingual immunotherapy (11.6%). Conclusions. Adherence rate in our study was 77%. Economic reasons were the main cause of abandonment in the first year, while the perception of non-improvement was the main reason for abandonment in subsequent years. Adequate information on SCIT prescribing and rigorous monitoring of patients during the treatment can improve adherence. |
id |
RCAP_26864256e8367ea5daed016b01eab789 |
---|---|
oai_identifier_str |
oai:comum.rcaap.pt:10400.26/33143 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real lifeallergysubcutaneous immunotherapyaeroallergensadherencePortugalrespiratory diseaseMadeira IslandIntroduction. Adherence in allergen immunotherapy is crucial for its efficacy. At least 3 years of treatment are recommended for achieving a long-term modifying effect. Objectives. To assess patient’s adherence and to identify determinant factors for allergen subcutaneous immunotherapy (SCIT) suspension in patients with respiratory allergy. Methods. Retrospective analysis of the medical record of patients submitted to SCIT between January 2013 and December 2016 in our Department. Results. 323 patients were included: 52% female; mean age 30 ± 13 years; average treatment time 19 ± 13 months. 52 patients (16%) stopped SCIT: 54% female; mean age 30 ± 9 years; average treatment time 12 ± 6 months; 67% dropped the treatment during the 1st year, 27% in the 2nd and 6% during the 3rd year of treatment. Adherence rate determined was 77%. The most frequent reasons for withdrawal were due to economic reasons (47.9%), followed by patients’ perception of no clinical improvement (23%) and change to sublingual immunotherapy (11.6%). Conclusions. Adherence rate in our study was 77%. Economic reasons were the main cause of abandonment in the first year, while the perception of non-improvement was the main reason for abandonment in subsequent years. Adequate information on SCIT prescribing and rigorous monitoring of patients during the treatment can improve adherence.Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri - AAIITORepositório ComumLourenço, TFernandes, MCoutinho, CLopes, ASpinola Santos, ANeto, MPereira Barbosa, M2020-08-18T14:49:58Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.26/33143engEur Ann Allergy Clin Immunol Vol 52, N.2, 84-90, 20201764-1489info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-10T02:16:51Zoai:comum.rcaap.pt:10400.26/33143Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:34:27.572192Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
title |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
spellingShingle |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life Lourenço, T allergy subcutaneous immunotherapy aeroallergens adherence Portugal respiratory disease Madeira Island |
title_short |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
title_full |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
title_fullStr |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
title_full_unstemmed |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
title_sort |
Subcutaneous immunotherapy with aeroallergens-evaluation of adherence in real life |
author |
Lourenço, T |
author_facet |
Lourenço, T Fernandes, M Coutinho, C Lopes, A Spinola Santos, A Neto, M Pereira Barbosa, M |
author_role |
author |
author2 |
Fernandes, M Coutinho, C Lopes, A Spinola Santos, A Neto, M Pereira Barbosa, M |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório Comum |
dc.contributor.author.fl_str_mv |
Lourenço, T Fernandes, M Coutinho, C Lopes, A Spinola Santos, A Neto, M Pereira Barbosa, M |
dc.subject.por.fl_str_mv |
allergy subcutaneous immunotherapy aeroallergens adherence Portugal respiratory disease Madeira Island |
topic |
allergy subcutaneous immunotherapy aeroallergens adherence Portugal respiratory disease Madeira Island |
description |
Introduction. Adherence in allergen immunotherapy is crucial for its efficacy. At least 3 years of treatment are recommended for achieving a long-term modifying effect. Objectives. To assess patient’s adherence and to identify determinant factors for allergen subcutaneous immunotherapy (SCIT) suspension in patients with respiratory allergy. Methods. Retrospective analysis of the medical record of patients submitted to SCIT between January 2013 and December 2016 in our Department. Results. 323 patients were included: 52% female; mean age 30 ± 13 years; average treatment time 19 ± 13 months. 52 patients (16%) stopped SCIT: 54% female; mean age 30 ± 9 years; average treatment time 12 ± 6 months; 67% dropped the treatment during the 1st year, 27% in the 2nd and 6% during the 3rd year of treatment. Adherence rate determined was 77%. The most frequent reasons for withdrawal were due to economic reasons (47.9%), followed by patients’ perception of no clinical improvement (23%) and change to sublingual immunotherapy (11.6%). Conclusions. Adherence rate in our study was 77%. Economic reasons were the main cause of abandonment in the first year, while the perception of non-improvement was the main reason for abandonment in subsequent years. Adequate information on SCIT prescribing and rigorous monitoring of patients during the treatment can improve adherence. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-08-18T14:49:58Z 2020 2020-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.26/33143 |
url |
http://hdl.handle.net/10400.26/33143 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Eur Ann Allergy Clin Immunol Vol 52, N.2, 84-90, 2020 1764-1489 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri - AAIITO |
publisher.none.fl_str_mv |
Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri - AAIITO |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134907024277504 |